Indicatrix (ICX) is a UK based contract research organisation which specialises in high-throughput oil encapsulated nano-crystallography. Founded by Dr Michael Hall and Dr Michael Probert in 2020 ICX offers a range of expertise in the field of X-Ray crystallography particularly applicable to the areas of 'uncrystallisable' compounds and polymorph mapping more so if the work involves mass-limited samples.
The use of our patented technology 'ENaCt' (“Encapsulated Nanodroplet Crystallisation of Organic-Soluble Small Molecules” Chem 2020, 6(7), 1755-1765) provides ICX with a powerful and unique tool in solid-state projects allowing the exploration of thousands of experimental spaces in a fraction of the time of standard approaches.
Company Details
- Founded
- -
- Address
- Newcastle, Ne1, Gb
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.indicatrix.co.uk
- Keywords
- X-Ray Crystallography, High-throughput, Crystal Structures, High Pressure Crystallography, Contract Research.
- HQ
- Newcastle
Indicatrix Crystallography Ltd Questions
Indicatrix Crystallography Ltd's website is http://www.indicatrix.co.uk
Indicatrix Crystallography Ltd's LinkedIn profile is https://uk.linkedin.com/company/indicatrix-crystallography-ltd
Indicatrix Crystallography Ltd's industry is
Pharmaceutical Manufacturing
Indicatrix Crystallography Ltd's top competitors are
Nanoesc Lab,
Hexislab,
Multichem Ltd,
Newcastle Research Tissue Biobank,
Derma Uk Ltd,
Alma Alquimista,
Crysyst Llc,
International Centre For Ecohydraulics Research (Icer),
Marrabio,
Vivo Biobank.
Indicatrix Crystallography Ltd's categories are Pharmaceutical Manufacturing
Indicatrix Crystallography Ltd's founding year is 2020
